XML 98 R79.htm IDEA: XBRL DOCUMENT
v3.24.0.1

GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Schedule of Goodwill (Details) - USD ($) |  | 12 Months Ended
--- | --- | ---
Nov. 01, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021
Goodwill [Roll Forward] |  |  |  |
Goodwill, beginning balance |  | $ 6,452,000,000 |  |
Impairments | $ 0 | 0 | $ (2,812,000,000) | $ 0
Goodwill, ending balance |  | 6,514,000,000 | 6,452,000,000 |
Operating Segments |  |  |  |
Goodwill [Roll Forward] |  |  |  |
Goodwill, beginning balance |  | 6,452,000,000 | 9,418,000,000 |
Impairments |  |  | (2,812,000,000) |
Measurement period adjustments |  |  | 49,000,000 |
Currency translation |  | 62,000,000 | (203,000,000) |
Reallocation of goodwill |  | 0 |  |
Goodwill, ending balance |  | 6,514,000,000 | 6,452,000,000 | 9,418,000,000
Medical Products and Therapies | Operating Segments |  |  |  |
Goodwill [Roll Forward] |  |  |  |
Goodwill, beginning balance |  | 0 | 0 |
Impairments |  |  | 0 |
Measurement period adjustments |  |  | 0 |
Currency translation |  | 46,000,000 | 0 |
Reallocation of goodwill |  | 1,195,000,000 |  |
Goodwill, ending balance |  | 1,241,000,000 | 0 | 0
Healthcare Systems and Technologies | Operating Segments |  |  |  |
Goodwill [Roll Forward] |  |  |  |
Goodwill, beginning balance |  | 3,988,000,000 | 6,786,000,000 |
Impairments |  |  | (2,812,000,000) |
Measurement period adjustments |  |  | 49,000,000 |
Currency translation |  | 1,000,000 | (35,000,000) |
Reallocation of goodwill |  | 0 |  |
Goodwill, ending balance |  | 3,989,000,000 | 3,988,000,000 | 6,786,000,000
Pharmaceuticals | Operating Segments |  |  |  |
Goodwill [Roll Forward] |  |  |  |
Goodwill, beginning balance |  | 0 | 0 |
Impairments |  |  | 0 |
Measurement period adjustments |  |  | 0 |
Currency translation |  | 21,000,000 | 0 |
Reallocation of goodwill |  | 542,000,000 |  |
Goodwill, ending balance |  | 563,000,000 | 0 | 0
Kidney Care | Operating Segments |  |  |  |
Goodwill [Roll Forward] |  |  |  |
Goodwill, beginning balance |  | 0 | 0 |
Impairments |  |  | 0 |
Measurement period adjustments |  |  | 0 |
Currency translation |  | 28,000,000 | 0 |
Reallocation of goodwill |  | 693,000,000 |  |
Goodwill, ending balance |  | 721,000,000 | 0 | 0
Americas |  |  |  |
Goodwill [Roll Forward] |  |  |  |
Goodwill, beginning balance |  | 1,965,000,000 | 2,099,000,000 |
Impairments |  |  | 0 |
Measurement period adjustments |  |  | 0 |
Currency translation |  | (27,000,000) | (134,000,000) |
Reallocation of goodwill |  | (1,938,000,000) |  |
Goodwill, ending balance |  | 0 | 1,965,000,000 | 2,099,000,000
EMEA |  |  |  |
Goodwill [Roll Forward] |  |  |  |
Goodwill, beginning balance |  | 289,000,000 | 309,000,000 |
Impairments |  |  | 0 |
Measurement period adjustments |  |  | 0 |
Currency translation |  | (4,000,000) | (20,000,000) |
Reallocation of goodwill |  | (285,000,000) |  |
Goodwill, ending balance |  | 0 | 289,000,000 | 309,000,000
APAC |  |  |  |
Goodwill [Roll Forward] |  |  |  |
Goodwill, beginning balance |  | 210,000,000 | 224,000,000 |
Impairments |  |  | 0 |
Measurement period adjustments |  |  | 0 |
Currency translation |  | (3,000,000) | (14,000,000) |
Reallocation of goodwill |  | (207,000,000) |  |
Goodwill, ending balance |  | $ 0 | $ 210,000,000 | $ 224,000,000

X
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(15)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(10)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1 + Details
Name: | us-gaap_Goodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2 + Details
Name: | us-gaap_GoodwillImpairmentLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 25 -Paragraph 16 -SubTopic 10 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479405/805-10-25-16 + Details
Name: | us-gaap_GoodwillPurchaseAccountingAdjustments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. + References No definition available. + Details
Name: | us-gaap_GoodwillRollForward
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 + Details
Name: | us-gaap_GoodwillTransfers
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 25 -Paragraph 16 -SubTopic 10 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479405/805-10-25-16 + Details
Name: | us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bax_MedicalProductsAndTherapiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bax_HealthcareSystemsAndTechnologiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bax_PharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bax_KidneyCareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=country_US
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=us-gaap_EMEAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=srt_AsiaPacificMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |